What we have to know about corticosteroids use during Sars-Cov-2 infection

PURPOSE: Glucocorticoids (GCs), alone or associated to other drugs, were widely used in the management of patients affected by severe acute respiratory syndrome caused by SARS-CoV-2 infection, during the recent COVID-19 outbreak. This review summarizes the available data on HPA axis impairment in GC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraù, F., Ceccato, F., Cannavò, S., Scaroni, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454136/
https://www.ncbi.nlm.nih.gov/pubmed/32860209
http://dx.doi.org/10.1007/s40618-020-01384-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454136/
https://www.ncbi.nlm.nih.gov/pubmed/32860209
http://dx.doi.org/10.1007/s40618-020-01384-5

Ejemplares similares